Novartis AG also holds 33.3% of the shares of Roche however, it does not
exercise control over Roche. Novartis also owned 24.9% of Idenix
Novartis chairman: business can help improve global health. Featured ... Novartis
focuses its business on three leading divisions with strong innovation power and
global scale: pharmaceuticals, eye care and generics. ... 2015 Novartis AG.
Novartis Pharmaceuticals Corporation (NPC) – a US affiliate of Basel,
Switzerland-based Novartis AG – is committed to the research and development
By Kathlyn Stone , About.com GuideJanuary 9, 2012
Swiss drug manufacturer Novartis
announced Sun., Jan. 8, that it is voluntarily recalling some lots of Excedrin, Bufferin, Gas-X and NoDoz from U.S. markets after receiving consumer complaints of chipped and broken pills... More »
Novartis Pharma AG company research & investing information. Find executives
and the latest company news.
Novartis Pharma AG (NVS) Unloads Certain Specialty Product Rights to Merus
for $29.5 Million 5/22/2015 5:19:32 AM · Ophthotech Corporation (OPHT) ...
Novartis Pharmaceuticals gives you an inside view of Novartis Pharmaceuticals
and help you see what drives us every day to do the work that we do.
The official international website of Novartis Oncology can help you learn more
about oncology ... 27-Sep-2015 New Novartis data in patients with GI or lung
which are sponsored by Novartis Pharma AG and which hyperlink to these Terms